- Home
- / Septerna
Septerna
Stock Price
$20
2024-10-29
Market Capitalization
$826.4 M
2024-10-29
Revenue
$46 M
FY, 2025
Septerna Summary
Company Summary
- Overview
- Septerna is a biotechnology company that provides drug discovery technology solutions. It develops novel small-molecule medicines targeting G protein-coupled receptors (GPCRs).
- Type
- Public
- Status
- Active
- Founded
- 2019
- HQ
- South San Francisco, CA, US | view all locations
- Website
- https://septerna.com
- Cybersecurity rating
Table of Contents
Key People
Amer Mirza, Vice President, Disease Biology and Translational Sciences
Alan Ezekowitz, Interim Chief Medical Officer
Chris Heise, Vice President, Discovery Biology
LocationsView all
1 location detected
South San Francisco, CA HQ
United States
250 E Grand Ave. #65
Septerna Financials
Summary Financials
- Revenue (Q1, 2026)
- $26.5M
- Net income (Q1, 2026)
- ($8.6M)
- Cash (Q1, 2026)
- $71.6M
- EBIT (Q1, 2026)
- ($13.3M)
- Enterprise value
- $777.9M